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 overrepresented within regions of DNA hypome-
thylation (P =4 . 2×1 0
−9;F i g .4 A ) .T h eL 1
insertion bias toward common hypomethylation
domains suggests that loss of DNA methylation
promotes integration of L1 instances. Supporting
this hypothesis, we find that the germline L1 in-
sertions are significantly enriched (P=3 . 0×1 0
−4)
in sperm-specific hypomethylation regions (7),
whereas somatic insertions are biased toward
cancer-specific hypomethylation regions (Fig. 4).
Our analysis suggests that some TE insertions
provide aselectiveadvantageduringtumorigenesis,
rather than being merely passenger events that
precede clonal expansion. We observed differen-
tial deregulation of TE activity across and within
different cancer types. We also found that such
insertions preferentially occur at genes commonly
mutated in cancer, including tumor suppressors,
substantially disrupting their expression. Although
a more extensive panel of matched genomic and
epigenetic data is needed to investigate the func-
tional impact of retrotransposition events and the
pathways involved, our analysis reveals the extent
of TE insertions in human tumors and lays the
foundation for determining the role of these events
in human neoplasia.
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Dense Chromatin Activates Polycomb
Repressive Complex 2 to Regulate
H3 Lysine 27 Methylation
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Polycomb repressive complex 2 (PRC2)–mediated histone H3 lysine 27 (H3K27) methylation is
vital for Polycomb gene silencing, a classic epigenetic phenomenon that maintains transcriptional
silencing throughout cell divisions. We report that PRC2 activity is regulated by the density of
its substrate nucleosome arrays. Neighboring nucleosomes activate the PRC2 complex with a
fragment of their H3 histones (Ala
31 to Arg
42). We also identified mutations on PRC2 subunit
Su(z)12, which impair its binding and response to the activating peptide and its ability in
establishing H3K27 trimethylation levels in vivo. In mouse embryonic stem cells, local chromatin
compaction occurs before the formation of trimethylated H3K27 upon transcription cessation
of the retinoic acid–regulated gene CYP26a1. We propose that PRC2 can sense the chromatin
environment to exert its role in the maintenance of transcriptional states.
P
olycomb repressive complex 2 (PRC2) is
a histone methyltransferase specific to his-
tone H3 Lys
27 (H3K27) (1–4), which regu-
lates Polycomb gene silencing and X chromosome
inactivation (5–9). E(z)/Ezh2, the subunit of PRC2
that contains the SET histone methyltransferase
domain, is inactive, and the presence of two other
essential subunits [ESC/EED and Su(z)12] is
required for enzyme activity (10). PRC2 can be
allosterically activated by trimethylated H3K27
(H3K27me3) (11) via its binding to ESC/EED
(11, 12). PRC2 has little activity on mononucleo-
somes but exhibits robust activity on dinucleo-
somes (13), suggesting that PRC2 activity might be
regulated by the density of its substrate chromatin.
We assembled three types of oligonucleosome
substrates differing in octamer/DNA ratio (Fig. 1A
and fig. S1). Reconstituted Drosophila PRC2
complex (fig. S2) exhibited robust activity on
dense oligonucleosomes and had far less activity
on dispersed oligonucleosomes, despite the pres-
ence of equal amounts of histones (Fig. 1B). The
results suggest that PRC2 activity might be reg-
ulated by two factors: the density of the substrate
nucleosome arrays and/or the DNA content. The
free DNA used for nucleosome assembly was ti-
trated into dense oligonucleosomes, which par-
tially inhibited PRC2 activity. However, PRC2
activity on dispersed oligonucleosomes remained
10-fold lower than that on the dense oligonucleo-
somes supplemented with higher amounts of free
DNA (Fig. 1B), suggesting that the density of the
substrate nucleosome arrays is a contributing fac-
tor in the regulation of PRC2 activity.
To verify our findings, we assembled mono-
and dinucleosomes with different linker DNA
(Fig. 1C). The strong nucleosome-positioning se-
quence 601 (14) was used to ensure the position
of the assembled nucleosomes (fig. S3). Mono-
nucleosomes were poor substrates, dinucleosomes
were much better substrates for PRC2 (Fig. 1D)
(10, 13), and PRC2 displayed lower activity on
dinucleosomeswith longer linkerDNA(Fig.1D).
Together, these results suggest that PRC2 activity
is sensitive to the density of its substrate chromatin.
PRC2 displayed much greater activity when
a neighboring nucleosome was present (Fig. 1),
suggesting that some feature(s) of the neighbor-
ing nucleosomes might activate PRC2. Indeed, a
fragment of histone H3 (amino acids 31 to 42)
(fig. S4A) greatly stimulated PRC2 enzyme activ-
ity (Fig. 1E) but not other tested histone methyl-
transferases (Fig. 1F and fig. S4). Scrambled
peptides with identical amino acid composition
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 displayed significantly reduced stimulation activ-
ity (fig. S5A). Moreover, the H3(31–42) peptide
robustly stimulated PRC2 enzyme activity on dis-
persed oligonucleosomes but displayed minimal
stimulation on dense oligonucleosomes (Fig. 2A).
The H3(31–42) peptide also robustly stimulated
PRC2’s activity on mononucleosomes (Fig. 2B),
eliminating the requirement for a neighboring
nucleosome. The human PRC2 complex was also
activated by the H3(31–42) peptide (fig. S5B),
indicating that thisactivation event isevolution-
arily conserved.
Several mutations were introduced into the
H3(31–42) peptide to elucidate which amino acid
residues are essential for the observed stimula-
tion. A minimal stimulating fragment (35 to 42)
was identified (fig. S5C), which greatly elevated
the maximum reaction rate (Vmax)o fP R C 2f o r
the poor substrates (mononucleosomes and dis-
persed oligonucleosomes) but had little impact
on the Vmax of PRC2 for the best substrates (dense
oligonucleosome arrays). In contrast, the stimulat-
ing peptide had a minor effect on the Michaelis
constant (Km) of PRC2 for all substrates (fig. S6).
Point mutations at Arg
40 (R40) greatly reduced the
stimulating activity (fig. S5C).
To confirm that nucleosome density is a con-
tributingfactorinthedistributionprofileofPRC2-
mediated H3K27me3 and dimethylated H3K27
(H3K27me2) in vivo, we performed a bioinformatics
analysis by using the published genome-wide
profiling of nucleosome position and various his-
tonemodificationsinhumanCD4
+Tcells(15,16).
First, we defined the well-positioned nucleosome
pairs, then we measured the distance between
the two nucleosomes in each pair, and last we
summed the chromatin immunoprecipitation
(ChIP)–sequencing reads that fell onto the paired
nucleosomes in order to represent their histone
modification levels. The percentage of nucleosome
pairs with high modification levels (reads > 3)
was plotted against the nucleosome spacing for
each modification (fig. S7). H3K27me3 and
H3K27me2, both mediated by PRC2, displayed
negativecorrelationsbetweentheirmodification
levels and the nucleosome spacing; H3K27me1
showed a lesser degree of negative correlation;
and the other histone modifications tested showed
noobviouscorrelation (fig.S7).Wethen performed
1000 rounds of randomization to redistribute the
ChIP-sequencingreadsontothese well-positioned
nucleosome pairs. The randomization test results
showed thatthe observed negative correlations of
H3K27me3 and H3K27me2 were statistically
significant (P < 0.001), whereas those of the other
modifications were not (fig. S8).
Although we have tested the impact of nu-
cleosome spacing on PRC2 activity, the allosteric
activation of PRC2 by neighboring nucleosomes
isunlikelytoberestrictedtoonedimension.Local
compaction of the nucleosome arrays is also fully
compatible with such activation. Indeed, PRC2
activity on dispersed oligonucleosomes, but not
core histones, was stimulated by 1 to 3 mM of
MgCl2 (Fig. 2C), which suggests that PRC2 fa-
vors substrates with a more compact chromatin
structure.Histone H1stimulated PRC2activity on
dinucleosomes but not mononucleosomes (13),
and histone H1 stimulated PRC2 activity on dis-
persed oligonucleosomes but not dense oligonu-
cleosomes (Fig. 2D). Moreover, no additive effect
between H3(31–42) peptide and histone H1-
mediatedPRC2activationwasobserved(Fig.2E),
suggesting that H1-mediated PRC2 activation is
likely caused by the compaction of the chromatin
and the resulting closer neighboring H3 histones.
To determine which subunit of the PRC2 com-
plex recognizes the H3(35–42) fragment, we syn-
thesized a 3,4-dihydroxyphenyl-alanine (DOPA)
andbiotindual-labeledH3(35–42)peptide(Fig.3A).
DOPA can be cross-linked to contacting proteins
with low background under periodate treatment
(17). DOPA-conjugated H3(35–42) peptide was
strongly cross-linked to Su(z)12 in the PRC2
complex (Fig. 3A) and weakly cross-linked to
ESC, but did not cross-link to histone methyl-
transferases NSD2 or Suv4-20h1 (fig. S9A). The
H3 Arg
40→Ala
40 (H3R40A) and His
39→Glu
39/
Arg
40→Glu
40 (H39E/R40E) mutant peptides dis-
played greatly reduced cross-linking signals (fig.
S9B). In contrast to the H3K27me3 peptide, the
H3(35–42) peptide did not interact with EED in
the isothermal titration calorimetry (ITC) assay
(fig. S10).
To map the critical region on Su(z)12 that
responded to the H3(35–42) peptide, we performed
Fig. 1. Neighboring nucleosomes activated PRC2
activity. (A) Substrate description. (B) PRC2 activity
was sensitive to the nucleosome density on oligo-
nucleosomes; the total DNA contents in lanes 1 to 7
are 6.75, 2.25, 0.75, 1.55, 2.35, 3.95, and 7.15 mg,
respectively. (C) Substrate description. (D)P R C 2a c -
tivity was sensitive to the nucleosome density on di-
nucleosomes. (E)H 3 ( 3 1 –42) peptide activated PRC2.
(F)H 3 ( 3 1 –42) peptide did not activate the other his-
tone methyltransferases tested. The amounts of his-
tone methyltransferases used were as follows: 1.6 mg
of NSD2, 20 ng of Dot1L, 100 ng of PRC2, 0.2 mgo f
P r - S e t 7 ,a n d8 0n go fS u v 4 - 2 0 h 1 .
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 systematic mutagenesis of Su(z)12 and purified
mutant PRC2 complexes by using the Baculo-
virus expression system (fig. S11). Deletion of
103 amino acids at the N terminus of Su(z)12
caused the loss of Nurf55 in the ternary com-
plex. Nevertheless, deletions of up to 506 amino
acids at the N terminus of Su(z)12 did not affect
the formation of active trimeric complexes with
E(z) and ESC (fig. S11A). We were able to
reconstitute a mutant PRC2 complex containing
E(z), ESC, and a truncated Su(z)12 (507 to 630)
(Fig. 3A), which can be cross-linked by the
DOPA-conjugated H3(35–42) peptide (Fig. 3A)
and robustly activated by the H3(35–42) peptide
(Fig. 3B).
This region (507 to 630) contains the highly
conserved VEFS-BOX (18) that is important for
PRC2 activity (19, 20) and includes many highly
Fig. 2. Neighboring nucleosomes activated PRC2 activity. (A) Stimulat-
ing behavior of H3(31–42) peptide on oligonucleosomes. (B) Stimulating
behavior of H3(31–42) peptide on mono- and dinucleosomes. (C) One to
3 mM MgCl2 stimulated PRC2 activity on dispersed oligonucleosomes but
not on core histones. (D) Histone H1 stimulated PRC2 activity on dis-
persed oligonucleosomes but not on dense oligonucleosomes. (E) Histone
H1 did not further activate PRC2 activity in the presence of the H3(31–42)
peptide.
Fig. 3. (A) DOPA-conjugated H3(35–42) peptide cross-linked onto Su(z)12 and Su(z)12(507–603)
fragment. The asterisk indicates a contamination band in the right lane; see also fig.
S 1 2 C .F ,P h e ;G ,G l y ;P ,P r o ;V ,V a l ;Y ,T y r .( B) PRC2 complex with Su(z)12(507–603)
was robustly activated by H3(35–42) peptide. (C) PRC2 complex with Su(z)12 mutant 26
lost its preference toward dense oligonucleosomes. (D) PRC2 complex with Su(z)12
mutant 26 was activated by the H3K27me3 peptide but not the H3(35–42) peptide. (E)
Mouse Su(z)12 mutant 26 was impaired in rescuing H3K27me3 levels in Su(z)12 null ES
cells.
www.sciencemag.org SCIENCE VOL 337 24 AUGUST 2012 973
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 conserved acidic residues (fig. S11B). Because
mutating a basic residue R40 or replacing H39
with an acidic residue greatly abolished the stim-
ulating activity of H3(35–42) peptide (fig. S5C),
we reasoned that some of these conserved acidic
residues on Su(z)12 might be required for its re-
sponse to the stimulating peptide. Therefore, we
reconstituted several PRC2 complexes containing
full-length Su(z)12 carrying various mutations at
these acidic residues (fig. S11C). One mutant com-
plex (mutant 26, E548A/E550A/D552A, where
D indicates Asp) completely lost its preference
toward dense oligonucleosomes (Fig. 3C). This
mutant complex can be robustly activated by the
H3K27me3 peptide but not the H3(35–42) peptide
(Fig. 3D). It also displayed reduced cross-linking
by the DOPA-conjugated H3(35–42) peptide (fig.
S12A). This mutant complex remained intact and
Fig. 4. Upon cessation of transcription of the CYP26a1 gene, chromatin
compaction occurred before the formation of H3K27me3. (A)T h eC Y P 2 6 a 1
promoter region with testing primers marked. (B) Experiment scheme. RA,
retinoic acid. (C) Reverse transcription polymerase chain reaction (RT-PCR) for
CYP26a1 mRNA levels. (D) Chromatin compaction began at 2 to 4 hours and
was complete at 8 hours after retinoic acid withdrawal. (E)H 3 K 2 7 m e 3e s t a b -
lishment began at 8 hours and was complete at 36 hours after retinoic acid
withdrawal. Error bars represent the standard deviation of three repeats.
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 displayed a subunit composition comparable to that
of the wild-type complex (fig. S12B). Moreover,
ectopic expression of wild-type mouse Su(z)12
efficiently rescued the deficiency of H3K27me3
levels in Su(z)12 null embryonic stem (ES) cells
(21),butectopicexpressionofcomparableamounts
of mouse Su(z)12 mutated at the same residues
showed a much poorer rescue effect (Fig. 3E).
These results collectively suggest that allosteric
activation of PRC2 by neighboring nucleosomes
is important for the establishment of H3K27me3
in vivo.
We propose that active genes are resistant to
PRC2 activity not only because they carry active
marks (such as H3K4me3, H3K36me2, and
H3K36me3) that antagonize PRC2 activity (20, 22)
but also because the chromatin of actively tran-
scribing genes is less compact, with a lower nu-
cleosome density and a lower linker histone H1
content (5). Once active transcription has ceased
upon transcription factor dissociation, either the
chromatin-remodeling events or the incorpora-
tion of additional histones (including linker his-
tones) would lead to higher nucleosome density,
higher H1 content, and more compact chromatin
structure, which in turn would convert these nu-
cleosomes from their inert status to ideal sub-
strates of PRC2. Thus, H3K27me3 could be
established and lead to further repression of the
target genes (fig. S13).
We studied the kinetics of chromatin com-
paction and H3K27me3 establishment in an
~ 1 . 8 - k br e g i o na r o u n dt h et r a n s c r i p t i o ns t a r ts i t e
of the CYP26a1 gene (Fig. 4A) upon transcrip-
tion cessation, because CYP26a1 is an induc-
ible gene regulated by retinoic acid (23)a n da
well-established Polycomb target repressed by
H3K27me3 (23, 24). Mouse ES cells were treated
with retinoic acid for 36 hours to induce CYP26a1
expression. Retinoic acid was then withdrawn
to end the induction, and the cells were har-
vested at various time points after retinoic acid
withdrawal (Fig. 4, B and C) to monitor the
dynamic changes of the chromatin compaction
status and H3K27me3 levels. The chromatin com-
paction status was determined by a nuclease ac-
cessibility assay (25). The tested regions displayed
much more “open” structures upon induction,
andthey began to belessaccessibleat 2to4 hours
and fully compacted at 8 hours after retinoic
acid withdrawal (Fig. 4D). The establishment of
H3K27me3 began at 8 hours and was complete
at 36 hours after retinoic acid withdrawal (Fig.
4E). These results suggest that the local chroma-
tin compaction precedes the establishment of
H3K27me3, in agreement with our model.
The ability of PRC2 to distinguish active
chromatin (open, marked by H3K4me3 and
H3K36me2/3) from inactive chromatin (dense,
marked by H3K27me3) provides a mechanistic
solution for its ability to maintain (but not to ini-
tiate) the inactive states of target genes (fig. S13).
Even so, compacted chromatin is not the sole
determinant of PRC2 activity. Specific recruit-
ment of PRC2 by Polycomb response elements
(PREs) and DNA methylation–mediated antago-
nistic effect on PRC2 (26) are also important
contributors for the overall landscape of PRC2-
mediated H3K27 methylation profile.
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Phosphofructokinase 1 Glycosylation
Regulates Cell Growth and Metabolism
Wen Yi,
1,2 Peter M. Clark,
1,2 Daniel E. Mason,
3 Marie C. Keenan,
4 Collin Hill,
4
William A. Goddard III,
5 Eric C. Peters,
3 Edward M. Driggers,
4 Linda C. Hsieh-Wilson
1,2*
Cancer cells must satisfy the metabolic demands of rapid cell growth within a continually changing
microenvironment. We demonstrated that the dynamic posttranslational modification of proteins
by O-linked b-N-acetylglucosamine (O-GlcNAcylation) is a key metabolic regulator of glucose
metabolism. O-GlcNAcylation was induced at serine 529 of phosphofructokinase 1 (PFK1) in
response to hypoxia. Glycosylation inhibited PFK1 activity and redirected glucose flux through the
pentose phosphate pathway, thereby conferring a selective growth advantage on cancer cells.
Blocking glycosylation of PFK1 at serine 529 reduced cancer cell proliferation in vitro and impaired
tumor formation in vivo. These studies reveal a previously uncharacterized mechanism for the
regulation of metabolic pathways in cancer and a possible target for therapeutic intervention.
R
apid physiological response is critical for
the growth of tumors, which must sat-
isfy the metabolic demands of increased
cell proliferation in the face of a dynamically
changing microenvironment. Cancer cells re-
program their cellular metabolism to generate
molecules such as adenosine triphosphate (ATP),
nucleotides, lipids, and reduced nicotinamide ad-
enine dinucleotide phosphate (NADPH) to fa-
cilitate macromolecular synthesis and maintain
redox homeostasis (1, 2). Although mutations
in tumor suppressors and oncogenic pathways
contribute to these altered metabolic phenotypes
(1–3), such changes are slower and relatively
static. In contrast, posttranslational modifica-
tions such as protein phosphorylation allow cells
to respond rapidly and reversibly to a wide range
of signals.
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